04:49:15 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Arev Nutrition Sciences Inc
Symbol AREV
Shares Issued 11,913,200
Close 2018-01-12 C$ 0.56
Market Cap C$ 6,671,392
Recent Sedar Documents

Arev appoints Sider CFO; Trinh resigns

2018-02-08 19:55 ET - News Release

Mr. Stephane Maher reports

AREV NUTRITION SCIENCES INC. ANNOUNCES DEREK SIDER AS CFO

Derek Sider has joined Arev Nutrition Sciences Inc. as chief financial officer, effective immediately.

Due to the current transaction between the company and We Grow B.C. Ltd. (WGBC), Long Trinh, currently chief financial officer of Arev, has resigned to focus his attention on matters relating to We Grow B.C. and closing the transaction with Arev announced on Jan. 17, 2018. The company is pleased to announce that Mr. Sider has been appointed, effective immediately, as chief financial officer.

Mr. Sider is an experienced financial professional with over 17 years in various international business roles.

Most recently, he spent six years in the mining industry in management roles ranging from M&A (mergers and acquisitions) to corporate administration and corporate tax. He has participated on a variety of international acquisitions, divestitures, joint ventures and other mining deals with values up to $2-billion. His experience includes corporate finance, corporate tax, securities and corporate law matters, public and private debt, deal negotiation, and corporate structuring.

Prior to that, he spent nine years at PricewaterhouseCoopers in a number of roles, including international tax in Vancouver and capital markets in New York, progressing to the senior manager level.

He has served on a number of non-profit boards, most recently as treasurer/finance committee chair at the Association of Neighborhood Houses, one of British Columbia's largest and oldest charities.

He is a designated chartered professional accountant (CGA) with a master in science (tax) with honours and is currently a candidate for a master in business law (Osgoode Law).

The company is also pleased to appoint Denby Greenslade as corporate secretary of Arev Nutrition Sciences, effective immediately. Ms. Greenslade has over 15 years of corporate secretarial, corporate governance and securities regulation experience with a focus on the neutraceutical and mining sector in Canada and Mexico. She has served in several senior management and executive roles for companies listed on the Toronto Stock Exchange, TSX Venture Exchange and Canadian Securities Exchange. During her career, she has been involved in numerous transactions and financings, and has led the evaluation, design, implementation and monitoring of governance programs for several junior mining companies.

Further, the company has hired a consultant with over 12 years of management experience at Telus to head a number of important human resources initiatives. Amongst other things, the consultant will assist with sourcing and place strategic individuals in key roles moving forward.

The company, effective immediately, has issued 405,000 stock options to officers and consultants of the company at a price of 56 cents for a period of five years from the issuance date. A total of 25,000 of these options will vest immediately with the remaining 380,000 options on a two-year vesting schedule: one-third immediately, one-third at the one-year mark and the final one-third at the end of the second year.

About Arev Nutrition Sciences Inc.

Arev Nutrition Sciences produces and delivers functional ingredients from its world-class extraction systems. Arev is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. Arev is also working with pharmacy and dispensary operators with an innovative emulsified base formula to disperse cannabis oil extracts from specific selected genetic cannabis strains that address five areas of health, including anxiety, pain management, insomnia, central nervous system disorders and libido.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.